Search Results - "BDEIR, K"

Refine Results
  1. 1
  2. 2

    Interaction of high-molecular-weight kininogen with endothelial cell binding proteins suPAR, gC1qR and cytokeratin 1 determined by surface plasmon resonance (BiaCore) by Pixley, R A, Espinola, R G, Ghebrehiwet, B, Joseph, K, Kao, A, Bdeir, K, Cines, D B, Colman, R W

    Published in Thrombosis and haemostasis (01-06-2011)
    “…The physiologic activation of the plasma kallikrein-kinin system requires the assembly of its constituents on a cell membrane. High- molecular-weight kininogen…”
    Get more information
    Journal Article
  3. 3

    Urokinase mediates fibrinolysis in the pulmonary microvasculature by Bdeir, Khalil, Murciano, Juan-Carlos, Tomaszewski, John, Koniaris, Lauren, Martinez, Jose, Cines, Douglas B., Muzykantov, Vladimir R., Higazi, Abd Al-Roof

    Published in Blood (01-09-2000)
    “…The role of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) in fibrinolysis remains unsettled. The contribution of uPA may depend on the…”
    Get full text
    Journal Article
  4. 4

    A Region in Domain II of the Urokinase Receptor Required for Urokinase Binding by Bdeir, K, Kuo, A, Mazar, A, Sachais, B S, Xiao, W, Gawlak, S, Harris, S, Higazi, A A, Cines, D B

    Published in The Journal of biological chemistry (15-09-2000)
    “…The urokinase receptor is composed of three homologous domains based on disulfide spacing. The contribution of each domain to the binding and activation of…”
    Get full text
    Journal Article
  5. 5

    Binding of urokinase plasminogen activator to gp130 via a putative urokinase-binding consensus sequence by Liang, Olin D, Chavakis, Triantafyllos, Linder, Monica, Bdeir, Khalil, Kuo, Alice, Preissner, Klaus T

    Published in Biological chemistry (01-02-2003)
    “…Urokinase-type plasminogen activator (uPA) and its receptor (uPAR) are instrumental in cellular activities during inflammation, angiogenesis and tumor…”
    Get more information
    Journal Article
  6. 6
  7. 7
  8. 8

    Novel Interactions between Urokinase and Its Receptor by Shliom, Ori, Huang, Mingdong, Sachais, Bruce, Kuo, Alice, Weisel, John W., Nagaswami, Chandrasekaran, Nassar, Taher, Bdeir, Khalil, Hiss, Edna, Gawlak, Susan, Harris, Scott, Mazar, Andrew, Higazi, Abd Al-Roof

    Published in The Journal of biological chemistry (11-08-2000)
    “…Urokinase-type plasminogen activator (uPA) binds to its receptor (uPAR) with a Kd of about 1 nm. The catalytic activity of the complex is apparent at uPA…”
    Get full text
    Journal Article
  9. 9

    The Structure of Lipoprotein(a) and Ligand-Induced Conformational Changes by Weisel, John W, Nagaswami, Chandrasekaran, Woodhead, John L, Higazi, Abd Al-Roof, Cain, William J, Marcovina, Santica M, Koschinsky, Marlys L, Cines, Douglas B, Bdeir, Khalil

    Published in Biochemistry (Easton) (04-09-2001)
    “…Lipoprotein(a) is composed of low-density lipoprotein linked both covalently and noncovalently to apolipoprotein(a). The structure of lipoprotein(a) and the…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Inhibition of ADAMTS13 Activity By Human Neutrophil Peptide 1 (HNP-1): Potential Link Between Inflammation, Onset of Thrombotic Thrombocytopenic Purpura, and Other Thrombosis by Bao, Jialing, Bdeir, Khalil, Siegel, Don L., Cines, Douglas B., Zheng, X. Long

    Published in Blood (06-12-2014)
    “…Thrombotic thrombocytopenic purpura (TTP) is a potentially fatal syndrome associated with severe deficiency of plasma ADAMTS13 activity resulting from either…”
    Get full text
    Journal Article
  13. 13

    Endothelial expression of E-selectin is induced by the platelet-specific chemokine platelet factor 4 through LRP in an NF-κB–dependent manner by Yu, Guangyao, Rux, Ann H., Ma, Peihong, Bdeir, Khalil, Sachais, Bruce S.

    Published in Blood (01-05-2005)
    “…The involvement of platelets in the pathogenesis of atherosclerosis has recently gained much attention. Platelet factor 4 (PF4), a platelet-specific chemokine…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Regulation of neovascularization by human neutrophil peptides (α‐defensins): a link between inflammation and angiogenesis by Chavakis, Triantafyllos, Cines, Douglas B., Rhee, Joong-Sup, Liang, Olin D., Schubert, Uwe, Hammes, Hans-Peter, Higazi, Abd Al-Roof, Nawroth, Peter P., Preissner, Klaus T., Bdeir, Khalil

    Published in The FASEB journal (01-08-2004)
    “…ABSTRACT Angiogenesis, the growth of new blood vessels, is a complex biological process that is orchestrated by several growth factors and components of the…”
    Get full text
    Journal Article
  16. 16

    Inhibition of pathologic retinal neovascularization by α-defensins by Economopoulou, Matina, Bdeir, Khalil, Cines, Douglas B., Fogt, Franz, Bdeir, Yasmina, Lubkowski, Jacek, Lu, Wuyuan, Preissner, Klaus T., Hammes, Hans-Peter, Chavakis, Triantafyllos

    Published in Blood (01-12-2005)
    “…Proliferative retinopathies, such as those complicating prematurity and diabetes, are major causes of blindness. A prominent feature of these retinopathies is…”
    Get full text
    Journal Article
  17. 17

    In vitro and in vivo effects of tPA and PAI-1 on blood vessel tone by Nassar, Taher, Akkawi, Sa’ed, Shina, Ahuva, Haj-Yehia, Abdullah, Bdeir, Khalil, Tarshis, Mark, Heyman, Samuel N., Higazi, Abd Al-Roof

    Published in Blood (01-02-2004)
    “…Tissue type plasminogen activator (tPA) is a key enzyme in the fibrinolytic cascade. In this paper we report that tPA contains 2 independent epitopes that…”
    Get full text
    Journal Article
  18. 18

    Blood clearance and activity of erythrocyte-coupled fibrinolytics by Ganguly, Kumkum, Krasik, Tatiana, Medinilla, Sandra, Bdeir, Khalil, Cines, Douglas B, Muzykantov, Vladimir R, Murciano, Juan Carlos

    “…Conjugating tissue-type plasminogen activator (tPA) to red blood cells (RBCs) endows it with features useful for thromboprophylaxis. However, the optimal…”
    Get more information
    Journal Article
  19. 19
  20. 20